Recornea
PrivateLast Round
Grant
Apr 16, 2025
Total Funding Raised
$3.33M
Company Overview
Recornea is a medical device company that develops minimally-invasive therapeutic solutions for treating corneal diseases such as keratoconus.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recornea Comparables
Compare Recornea with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AJL Ophthalmic | 81% | |
| LinkoCare Life Sciences | 80% | |
| CorNeat Vision | 77% |
Recornea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2025 | ||||
| Seed | Mar 15, 2025 | ||||
| Pre Seed | Sep 1, 2021 |
Recornea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| B Heroes | Seed |
| Scientifica Venture Capital | Seed |
| G-Factor | Accelerator, Pre Seed |
| Medical Technology Enterprise Consortium | Grant |
| Entrepreneurs First | Accelerator, Pre Seed |
| ENEA-Tech and Biomedical Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2025
$2.1M grant from Medical Technology Enterprise Consortium
- Mar 15, 2025
$1.2M round led by ENEA-Tech and Biomedical Foundation.
Recornea Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Recornea's valuation, stock price, and market status.
Is Recornea a public or private company?
Recornea is a private company.
What is the current stock price of Recornea?
Recornea is a private company with no public stock price. No recent secondary market data is available.
How much is Recornea worth (valuation)?
Valuation information for Recornea is not publicly available.
Can I buy Recornea stock?
Recornea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Recornea's last funding round?
Recornea's most recent funding round was Grant on April 16, 2025.
Who are the main investors in Recornea?
Key investors in Recornea include Medical Technology Enterprise Consortium.
Will Recornea IPO soon?
No public IPO plans have been announced for Recornea.
How can I track Recornea secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Recornea's secondary market activity and sign up for updates.